Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
654
datasets available to search
ShareScore release 0.9.0
Dataset results
654 results for “estrogen receptor”
16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer
ClinicalTrials.gov study NCT04150731. IPD Sharing: NO. Countries: 1. Publications: 1.
Estrogen Receptor 1 Gene Polymorphism Frequency in Fibromyalgia Syndrome
ClinicalTrials.gov study NCT03786393. IPD Sharing: NO. Countries: 1. Publications: 7.
Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA)
ClinicalTrials.gov study NCT03065621. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
ClinicalTrials.gov study NCT03332797. IPD Sharing: NO. Countries: 5. Publications: 2.
Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia
ClinicalTrials.gov study NCT02354001. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT05654532. IPD Sharing: NO. Countries: 1. Publications: 1.
Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Ef
ClinicalTrials.gov study NCT04629846. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women
ClinicalTrials.gov study NCT01069211. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?
ClinicalTrials.gov study NCT01481883. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase IB Study to Evaluate RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Cancer
ClinicalTrials.gov study NCT02650817. IPD Sharing: NO. Countries: 2. Publications: 1.
Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
ClinicalTrials.gov study NCT04568902. IPD Sharing: YES. Countries: 1. Publications: 1.
Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
ClinicalTrials.gov study NCT05872204. IPD Sharing: NO. Countries: 3. Publications: 1.
Comparison of Cardiotoxicity Induced by Selective Estrogen REceptor Modulators and aNti-Aromatase
ClinicalTrials.gov study NCT03259711. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep Apnea
ClinicalTrials.gov study NCT03981341. IPD Sharing: NO. Countries: 1. Publications: 4.
A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT02053636. IPD Sharing: YES. Countries: 9. Publications: 1.
Estrogen Receptors and Peripheral Artery Disease
ClinicalTrials.gov study NCT04419727. IPD Sharing: NO. Countries: 1. Publications: 6.
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Gr
ClinicalTrials.gov study NCT03725059. IPD Sharing: YES. Countries: 24. Publications: 2.
Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer
ClinicalTrials.gov study NCT00283608. IPD Sharing: Not stated. Countries: 1. Publications: 3.
4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT01626222. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Phase I, Multicenter, Open-Label, Multi-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT02338349. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.